Long Ideas - Questcor Pharmaceuticals’ (QCOR) purchase of Synacthen on Tuesday, a synthetic melanocortin receptor agonist, from Novartis (NVS) is good news for the $2B drug developer, fortifying … Continue Reading
Read nowLong Ideas - News that Amarin Corp. (AMRN) is preparing for an FDA advisory panel regarding Vascepa in the Anchor indication caught investors off guard last Thursday, introducing … Continue Reading
Read nowLong Ideas - Endo Health Solutions’ (ENDP) new CEO is executing on his strategy, as expected, and most of the Street likes what it sees. Endo announced on … Continue Reading
Read nowShort Ideas - Zogenix (ZGNX) in a press release Wednesday morning said that it is undertaking cost-control initiatives in order to achieve key business milestones in 2013, including: … Continue Reading
Read nowLong Ideas - BioMarin (BMRN) took a beating on Monday as more mature data at the American Society for Clinical Oncology meeting for its Phase I PARP inhibitor, … Continue Reading
Read nowLong Ideas - ResMed Inc. (RMD), a developer of continuous positive airway pressure (CPAP) devices, is suing fellow CPAP manufacturer and low-cost competitor 3B Medical for patent infringement. … Continue Reading
Read nowLong Ideas - Keryx Biopharmaceuticals (KERX) presented additional details from its pivotal Phase III study for Zerenex Monday at the World Congress of Nephrology (WVN) meeting during a … Continue Reading
Read now